Barts Revascularisation Registry to Study Patient Characteristics and Outcomes After Coronary Artery Disease Treatment at Barts Heart Centre

What this Trial Is About

Researchers are studying coronary artery disease CAD, a leading cause of death worldwide, by collecting real-world data from patients undergoing revascularisation at Barts Heart Centre. This observational research aims to understand patient characteristics, treatment trends, and outcomes to improve risk assessment and diagnostic evaluation. The study builds on a long history of data collection in the UK and focuses on patients with CAD receiving interventional or surgical treatments. The study involves patients who have undergone percutaneous coronary intervention PCI or coronary artery bypass grafting CABG at the centre. Data is collected through a secure clinical database containing demographic, clinical, and outcome information. Patients are observed without additional treatment interventions as part of the study. This registry includes a wide range of patients with simple to complex coronary artery disease. Participants data will be used to monitor outcomes such as mortality, re-admission rates, and major adverse cardiovascular events MACE within one year after revascularisation. The study does not require informed consent as data collection is part of routine care. The research will provide valuable real-world evidence on the safety, feasibility, and effectiveness of current revascularisation practices in a leading cardiac centre.

Barts Revascularisation Registry